Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2018-10-22 2018-10-22
Drug Identification Number 02428652 02428652
Brand name ACT TADALAFIL ACT TADALAFIL
Common or Proper name TADALAFIL TADALAFIL
Company Name ACTAVIS PHARMA COMPANY ACTAVIS PHARMA COMPANY
Ingredients
Strength(s)
Dosage form(s)
Route of administration
Packaging size 4 4
ATC code
ATC description
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-05-31 2018-05-31
Remaining supply date 2018-05-31 2018-05-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments Transitioned. TEVA available Transitioned. TEVA available
Health Canada comments